BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 6276937)

  • 1. [Role of A virus in the genesis of chronic hepatitis and distribution of its antibodies in the current adult Spanish population].
    Jiménez-Saenz M; Herrerias JM; Pérez-Cano R; Pineda A; Garrido M
    Rev Clin Esp; 1981 Sep; 162(6):269-70. PubMed ID: 6276937
    [No Abstract]   [Full Text] [Related]  

  • 2. [Prevalence of anti-HAV in the Spanish population].
    Carreño García V; González Alonso R; Porres Cubero JC; Ortiz Masllorens F; Martín Calderín F; Hernández Guío C
    Rev Esp Enferm Apar Dig; 1983 Sep; 64(3):187-90. PubMed ID: 6316427
    [No Abstract]   [Full Text] [Related]  

  • 3. [Epidemiological study of hepatitis A using the measurement of anti-VHA antibody].
    Grau A; Bertomeu F; Luna J; Llorente A; Vich JM; Anguiz A; Albero J; Bofill D; Simo E
    Rev Clin Esp; 1982 Apr; 165(1):11-3. PubMed ID: 6289388
    [No Abstract]   [Full Text] [Related]  

  • 4. [The hepatitis A virus antibody (anti-HAV) in chronic diffuse liver diseases].
    Dávid K; Halmy L
    Orv Hetil; 1983 May; 124(21):1241-3. PubMed ID: 6308536
    [No Abstract]   [Full Text] [Related]  

  • 5. [Hepatitis A virus infection, an etiologic factor in chronic active diseases of the liver? IgM antibody of the hepatitis A virus].
    Dávid K; Halmy L
    Orv Hetil; 1986 Feb; 127(5):261-3. PubMed ID: 3005941
    [No Abstract]   [Full Text] [Related]  

  • 6. [Anti-HA antibodies in a sample of an apparently healthy population of the province of Sassari].
    Romano G; Ginanneschi R; Mura I; Spano E
    Nuovi Ann Ig Microbiol; 1981; 32(4):239-46. PubMed ID: 6287434
    [No Abstract]   [Full Text] [Related]  

  • 7. The prevalence of antibodies to hepatitis A and B viruses in Port Chalmers residents.
    Austin FJ; Maguire T; Jennings LC; MacDiarmid RD
    N Z Med J; 1982 Feb; 95(701):72-3. PubMed ID: 6281700
    [No Abstract]   [Full Text] [Related]  

  • 8. Hepatits A virus infection in fulminant hepatitis and chronic active hepatitis.
    Rakela J; Redeker AG; Edwards VM; Decker R; Overby LR; Mosley JW
    Gastroenterology; 1978 May; 74(5 Pt 1):879-82. PubMed ID: 205479
    [No Abstract]   [Full Text] [Related]  

  • 9. [Anti-hepatitis virus antibodies in hospital personnel].
    Puelma E; Velasco M
    Rev Med Chil; 1983 Oct; 111(10):1033-4. PubMed ID: 6328608
    [No Abstract]   [Full Text] [Related]  

  • 10. Progress in hepatitis research.
    Silver S
    Am J Med Technol; 1975 Apr; 41(4):154-6. PubMed ID: 165721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis A virus: identification, characterization, and epidemiologic investigations.
    Dienstag JL
    Prog Liver Dis; 1979; 6():343-70. PubMed ID: 232281
    [No Abstract]   [Full Text] [Related]  

  • 12. Anti-HAV in Thai population.
    Viranuvatti V; Hemindra P; Chainuvati T
    J Med Assoc Thai; 1982 Jul; 65(7):379-82. PubMed ID: 6292320
    [No Abstract]   [Full Text] [Related]  

  • 13. Hepatitis markers detected in a Canadian blood donor population.
    Buchner BK; Staszak M; Duravetz J; Moore BP
    Acta Haematol Pol; 1980; 11(2):69-71. PubMed ID: 6252746
    [No Abstract]   [Full Text] [Related]  

  • 14. [Indications and prescription of hepatitis A vaccine in Spain. Report of the Spanish Association for the Study of the Liver].
    Bruguera M; Buti M; Diago M; García Bengoechea M; Jara P; Pedreira JD; Ruiz Estremera A
    Med Clin (Barc); 1998 Sep; 111(9):341-6. PubMed ID: 9810537
    [No Abstract]   [Full Text] [Related]  

  • 15. [Seroepidemiologic survey of hepatitis A antibodies in the young adult Spanish population. Spanish Study Group on hepatitis A (1)].
    González A; Bruguera M; Calbo Torrecillas F; Monge V; Dal-Ré R; Costa J
    Med Clin (Barc); 1994 Oct; 103(12):445-8. PubMed ID: 7996891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Silent infection by the hepatitis A virus].
    Yang NY
    Zhonghua Yi Xue Za Zhi; 1986 Sep; 66(9):528-30, 576. PubMed ID: 3024781
    [No Abstract]   [Full Text] [Related]  

  • 17. [Seroprevalence of hepatitis A antibodies in patients with chronic hepatitis].
    Bañares R; Bory F; Costa J; Dal-Ré R; González A; Navasa M; Planas R; Sansó A; Vargas V
    Gastroenterol Hepatol; 1996 Mar; 19(3):183. PubMed ID: 8991665
    [No Abstract]   [Full Text] [Related]  

  • 18. [Significance of the level of specific antibodies in the development of the icteric and inapparent forms of viral hepatitis A].
    Katkov AI
    Voen Med Zh; 1987 Apr; (4):32. PubMed ID: 3037788
    [No Abstract]   [Full Text] [Related]  

  • 19. [Serum immunoglobulin level of viral hepatitis patients at different stages of the disease].
    Nagornova TF; Marichev IL; Raksha EA; Markov IS
    Vrach Delo; 1983 Nov; (11):115-6. PubMed ID: 6318447
    [No Abstract]   [Full Text] [Related]  

  • 20. [Anti hepatitis A antibodies in healthy children and in patients with hepatitis (author's transl)].
    Zacarias J; Rakela J; Riveros C; Brinck P
    Rev Med Chil; 1981 Sep; 109(9):833-6. PubMed ID: 6281872
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.